Global experts and NHS specialists join AMMF to reduce lives lost to lethal liver cancer

Contributed by: PA Media Press Centres

Logo

AMMF’s Rethink Liver Cancer report reveals significant inequalities in access to treatment and survival rates for NHS patients with cholangiocarcinoma

Images

AMMF Logo

Tags

Liver Cancer

AMMF

More Like This

A rapid, non-invasive, clinical surveillance for CachExia, sarcopenia, portal hypertension, and hepatocellular carcinoma in end-stage liver disease: the ACCESS-ESLD study protocol (Photo: Business Wire)

Baseline Enrollment Completed for AMRA Medical and Linköping University’s Landmark Liver Disease Study

PR Newswire associated0

2024 American Oncology Annual Meeting Concludes in Chicago, CANCER CASES SURGE IN WESTERN COUNTRIES, Cancer Driver Interception: Active Prevention Strategy to Reduce Disease Burden

GlobeNewswire associated0

KFSHRC Concludes Participation at AMEE 2024 in Switzerland

PR Newswire associated0

Children's Tumor Foundation Presents the 2024 Global NF Conference in Brussels: Shaping What's Next for NF

PR Newswire associated0

Burjeel Holdings Oncology Conference Marks 10 Years, Focusing on Equitable Solutions for Cancer Care

PR Newswire associated0

Regional and Global Experts Convene in Accra, Ghana to Update Cancer Treatment Guidelines for Sub-Saharan Africa

PR Newswire associated0

International Collaboration to Improve Cancer Care in Sub-Saharan Africa Updates Resources for Sixth Year

Global Leaders Gather to Exchange Best Practices in Liver Health Policy